PSYBIO THERAPEUTICS CORP's ticker is and the CUSIP is 693697104. A total of 1 filers reported holding PSYBIO THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,263 | -62.0% | 2,994,817 | +6.9% | 0.01% | -62.5% |
| Q2 2023 | $56,005 | -57.2% | 2,800,225 | +8.4% | 0.02% | -61.0% |
| Q1 2023 | $130,964 | +92.0% | 2,583,122 | 0.0% | 0.04% | +115.8% |
| Q4 2022 | $68,194 | -72.1% | 2,583,122 | 0.0% | 0.02% | -71.2% |
| Q3 2022 | $244,000 | +23.2% | 2,583,122 | 0.0% | 0.07% | +20.0% |
| Q2 2022 | $198,000 | -18.9% | 2,583,122 | 0.0% | 0.06% | +37.5% |
| Q1 2022 | $244,000 | -10.0% | 2,583,122 | +52.7% | 0.04% | +21.2% |
| Q4 2021 | $271,000 | +401.9% | 1,691,178 | +648.8% | 0.03% | +266.7% |
| Q3 2021 | $54,000 | – | 225,864 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 2,583,122 | $198,000 | 0.06% |